Finally, Liao et al, also had COVID-19–infected BAL samples that demonstrated significantly more CK.AMs and IFN.AMs present compared with healthy control samples (Liao et al, 2020), suggesting a functional shift in proinflammatory AM subtypes during SARS-CoV-2 infection. The gene discussed is IFNA1; the disease is COVID-19.